Laser Components USA, Inc., located in Bedford, New Hampshire, is the exclusive distributor in the US and Canada for CODIXX, a manufacturer of dichroic glass polarizers for the ultraviolet, visible, and infrared spectral ranges. These polarizers are distributed under the brand name "colorPol®". All colorPol® polarizers fully comply with RoHS, REACH, and PFOS.
CODIXX is a corporation under German law, established in 1998.
The general markets served by colorPol® polarizers are optical telecommunication, medical and life science, space industry, semiconductor industry, R&D, displays, and measurement instrumentation, just to mention a few.
A colorPol® polarizer is an easy-to-use polarizer with exceptional polarization characteristics. It comes as a thin glass plate with a thickness of less than 300 μm and can be processed like glass. It is resistant to UV radiation, solvents, most acids and bases and complies with international RoHS regulations. It works at temperatures from below -50 °C (-58°F) to above 400 °C (+750 °F). In UV, VIS, NIR, and MIR range (340 nm up to 5 μm) these polarizers feature a high acceptance angle of ± 20°, high transmittance up to 98%, a very high contrast up to 107:1.
Laser Components USA, Inc: Bedford, NH, USA
CODIXX: Barleben, Germany
CODIXX - Laser Components USA, Inc.
116 South River Road
Building C
Bedford, NH 03110
TELEPHONE
(603) 821-7040
FAX
(603) 821-7041
E-MAILinfo@laser-components.com
WEB SITEwww.laser-components.com
NUMBER OF EMPLOYEES
Laser Components: 150+
CODIXX: 35+
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.